About the Journal

Journal of Antibiotics and Antimicrobial Agents is an international, peer-reviewed, open access journal dedicated to publishing high-quality research and scholarly contributions in the fields of antibiotics, antimicrobial agents, infectious diseases, microbiology, pharmacology, and antimicrobial therapeutics. The journal provides a global platform for scientists, clinicians, researchers, healthcare professionals, and pharmaceutical experts to share innovative discoveries, clinical advancements, and emerging developments that contribute to the prevention, diagnosis, and treatment of infectious diseases.

In an era of increasing antimicrobial resistance and the emergence of multidrug-resistant pathogens, the development and responsible use of effective antimicrobial therapies have become more important than ever. The Journal of Antibiotics and Antimicrobial Agents was established with the vision of promoting excellence in antimicrobial research and facilitating the global exchange of scientific knowledge that bridges fundamental laboratory discoveries with clinical applications.

The journal welcomes original and significant contributions that advance the understanding of antimicrobial mechanisms, microbial pathogenesis, antibiotic resistance, antimicrobial susceptibility, and therapeutic strategies. By maintaining a strong commitment to scientific rigor, research quality, and ethical publishing practices, the journal aims to ensure that published work contributes meaningfully to the advancement of antimicrobial science and healthcare.

As an international journal, the Journal of Antibiotics and Antimicrobial Agents welcomes submissions from researchers, clinicians, academic institutions, healthcare organizations, and pharmaceutical research centers worldwide. The journal encourages interdisciplinary collaboration and the exchange of knowledge among experts from diverse scientific and clinical backgrounds to support the development of innovative solutions to global challenges in infectious diseases and antimicrobial resistance.

The journal provides equal opportunities for researchers worldwide to disseminate their findings, promoting inclusivity and diversity in scientific communication. Through global participation and collaboration, the journal seeks to strengthen international efforts toward the discovery of novel antimicrobial agents, improved therapeutic approaches, and effective strategies for combating drug-resistant infections.

Peer Review Excellence

The journal follows a rigorous double-blind peer review process, ensuring that both authors and reviewers remain anonymous throughout the evaluation process. This approach eliminates bias and guarantees a fair, objective, and transparent review of all submitted manuscripts.

Each submission undergoes a thorough assessment by qualified experts in the relevant field, who evaluate the manuscript based on originality, scientific validity, methodological soundness, and relevance to the journal’s focus. The editorial board carefully considers reviewers’ feedback before making final decisions regarding acceptance, revision, or rejection.

To meet the needs of researchers requiring timely publication, the journal also offers a fast-track review process, enabling rapid evaluation and publication of high-priority manuscripts without compromising the quality of peer review. This feature is particularly beneficial for time-sensitive research findings and emerging scientific developments.

Open Access Policy and Creative Commons Licensing

Journal of Antibiotics and Antimicrobial Agents operates under a full open access publishing model, ensuring that all articles are freely accessible to readers worldwide without subscription barriers. This approach enhances the dissemination and impact of research, allowing knowledge to reach a broader audience including researchers, clinicians, policymakers, and the general public.

All published articles are distributed under Creative Commons licensing, which permits users to read, download, copy, distribute, and reproduce the content in any medium, provided that appropriate credit is given to the original authors. This policy supports the principles of transparency, accessibility, and knowledge sharing in scientific research.

Open access publishing not only increases the visibility of authors’ work but also contributes to higher citation rates and broader academic recognition.

Digital Identification and Indexing Support

To ensure the long-term accessibility and traceability of published research, the journal assigns a Digital Object Identifier (DOI) to each article through Crossref. This enables accurate citation, easy retrieval, and integration with global research databases.

In addition, all published articles are submitted for indexing in Google Scholar after publication, enhancing discoverability and ensuring that research is accessible to the global academic community. The journal continuously works toward inclusion in additional indexing and abstracting databases to further expand its reach and credibility

Language and Accessibility

The journal publishes all manuscripts in English, the universally accepted language of scientific communication. This ensures clarity, consistency, and accessibility for an international audience.

Authors are encouraged to present their research in a clear and concise manner, enabling readers from diverse academic and professional backgrounds to understand and apply the findings effectively. The journal also supports the use of standardized scientific terminology and formatting to maintain consistency across publications.

Ethical Standards and Integrity

The journal is committed to maintaining the highest standards of publication ethics and academic integrity. All submissions are expected to be original and free from plagiarism, data fabrication, or any form of unethical practice.

Authors are required to disclose any potential conflicts of interest and ensure that their research complies with ethical guidelines, particularly in studies involving human participants or animals. The journal follows internationally recognized ethical standards to safeguard the credibility and reliability of published research.

By enforcing strict ethical policies, the journal ensures trust among authors, reviewers, and readers.

Contribution to Scientific Advancement

The primary goal of the Journal of Antibiotics and Antimicrobial Agents is to contribute to the advancement of scientific knowledge and healthcare by promoting high-quality research in antibiotics and antimicrobial therapeutics. The journal encourages innovative studies addressing emerging infectious diseases, antimicrobial resistance, novel antimicrobial compounds, antibiotic development, microbial susceptibility, drug mechanisms, and therapeutic interventions.

The journal welcomes research that contributes to the discovery and development of new antimicrobial agents, improved treatment strategies, optimized antibiotic use, and effective approaches for addressing resistant pathogens. It also supports interdisciplinary research that translates laboratory discoveries into practical clinical and public health applications.

By promoting scientific excellence, accessibility, ethical research, and international collaboration, the Journal of Antibiotics and Antimicrobial Agents aims to serve as a valuable source of knowledge for the global scientific and medical community.

By fostering innovation and ensuring the widespread availability of research findings, the journal contributes to ongoing global efforts to combat antimicrobial resistance, improve the management of infectious diseases, advance antimicrobial therapies, and ultimately support better health outcomes worldwide.